Position in ALKS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$28,499,102
+$17,254,905 QoQ
Shares Held
543,876
+71.0% QoQ
Ownership
0.324%
of shares outstanding
% of Portfolio
5.59%
of 13F equity value
Holder Rank
#54
of 423 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Spruce Street Capital LP holds $87,209,678 across 2 Drug Manufacturers - Specialty & Generic names. ALKS ranks #2 (32.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
918,070 | $58,710,576 | |
| 2 | ALKS |
Alkermes plc.
This page
|
543,876 | $28,499,102 |
All Filings in ALKS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,499,102 | 543,876 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $11,244,197 | 317,992 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||